BSE Live
Jan 13, 16:01Prev. Close
172.80
Open Price
172.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 13, 15:59Prev. Close
172.98
Open Price
173.94
Bid Price (Qty.)
173.55 (100)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Marksans Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.27 | -0.23 | 0.43 | 1.89 | 6.37 | |
| Diluted EPS (Rs.) | -0.27 | -0.23 | 0.43 | 1.89 | 6.37 | |
| Cash EPS (Rs.) | 0.17 | 0.22 | 0.72 | 4.13 | 8.80 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 4.04 | 3.74 | 3.58 | 31.41 | 29.53 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 4.04 | 3.74 | 3.58 | 31.41 | 29.53 | |
| Revenue from Operations/Share (Rs.) | 9.72 | 9.69 | 7.17 | 64.47 | 80.67 | |
| PBDIT/Share (Rs.) | 0.69 | 0.80 | 1.16 | 7.83 | 13.92 | |
| PBIT/Share (Rs.) | 0.27 | 0.39 | 0.90 | 5.80 | 11.68 | |
| PBT/Share (Rs.) | -0.25 | -0.20 | 0.57 | 2.60 | 8.74 | |
| Net Profit/Share (Rs.) | -0.26 | -0.22 | 0.44 | 1.86 | 6.37 | |
| NP After MI And SOA / Share (Rs.) | -0.27 | -0.23 | 0.43 | 1.89 | 6.37 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.12 | 8.28 | 16.16 | 12.15 | 17.25 | |
| PBIT Margin (%) | 2.79 | 3.97 | 12.56 | 8.98 | 14.47 | |
| PBT Margin (%) | -2.58 | -2.01 | 7.95 | 4.02 | 10.83 | |
| Net Profit Margin (%) | -2.69 | -2.23 | 6.09 | 2.88 | 7.89 | |
| NP After MI And SOA Margin (%) | -2.80 | -2.34 | 5.98 | 2.92 | 7.89 | |
| Return on Networth/Equity (%) | -6.80 | -6.10 | 12.01 | 6.00 | 21.56 | |
| Return on Capital Employed (%) | -2.02 | -1.67 | 3.57 | 1.65 | 5.59 | |
| Return on Assets (%) | -1.52 | -1.30 | 2.74 | 1.36 | 4.87 | |
| Total Debt/Equity (X) | 2.87 | 2.90 | 2.63 | 2.82 | 2.86 | |
| Asset Turnover Ratio (%) | 54.35 | 55.53 | 45.84 | 46.44 | 61.77 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.59 | 1.84 | 2.22 | 3.98 | 5.69 | |
| Quick Ratio (X) | 0.94 | 1.00 | 1.15 | 2.60 | 4.37 | |
| Inventory Turnover Ratio (X) | 3.42 | 2.99 | 1.85 | 1.87 | 3.67 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | -6.53 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 7.17 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 106.53 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 92.83 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 0.52 | 0.66 | 2.73 | 1.81 | 3.97 | |
| Interest Coverage Ratios (Post Tax) (%) | 0.52 | 0.66 | 2.73 | 1.81 | 3.97 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 582.43 | 540.65 | 956.75 | 356.96 | 936.51 | |
| EV/Net Operating Revenue (X) | 1.63 | 1.52 | 3.71 | 1.54 | 3.23 | |
| EV/EBITDA (X) | 22.86 | 18.31 | 22.97 | 12.68 | 18.72 | |
| MarketCap/Net Operating Revenue (X) | 0.50 | 0.43 | 2.59 | 0.79 | 2.82 | |
| Retention Ratios (%) | 0.00 | 106.53 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.22 | 1.11 | 5.19 | 1.62 | 7.70 | |
| Price/Net Operating Revenue | 0.50 | 0.43 | 2.59 | 0.79 | 2.82 | |
| Earnings Yield | -0.06 | -0.05 | 0.02 | 0.04 | 0.03 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y